BROADWOOD CAPITAL INC Long-Term Concentrated

Location: New York, NY

CIK: 0001278387 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $1.304B (100.0% shares, 0.0% debt)

Holdings (7)

MNST MONSTER BEVERAGE CORP NEW 33.2%

Value $433M Shares 8,295,690 Est. Cost $36.99 Unrealized +33.9%

STAA STAAR SURGICAL CO 30.7%

Value $400M Shares 10,768,431 Est. Cost $14.70 Unrealized +153.7%

AXON AXON ENTERPRISE INC 23.3%

Value $304M Shares 760,062 Est. Cost $27.50 Unrealized +1153.8%

IWM ISHARES TR 8.8%

Value $115M Shares 519,920 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 2.9%

Value $37.72M Shares 41,666,255 Est. Cost $1.06 Unrealized -12.5%

IMDX ONCOCYTE CORP 1.1%

Value $14.05M Shares 4,929,066 Est. Cost $3.24 Unrealized -4.3%

SER SERINA THERAPEUTICS INC 0.0%

Value $570K Shares 85,219 Est. Cost $14.17 Unrealized -44.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	8,295,690	$433M	33.2%	$36.99	+33.9%	COM	61174X109
STAA	STAAR SURGICAL CO	10,768,431	$400M	30.7%	$14.70	+153.7%	COM PAR $0.01	852312305
AXON	AXON ENTERPRISE INC	760,062	$304M	23.3%	$27.50	+1153.8%	COM	05464C101
IWM	ISHARES TR	519,920	$115M	8.8%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS IN	41,666,255	$37.72M	2.9%	$1.06	-12.5%	COM	53566P109
IMDX	ONCOCYTE CORP	4,929,066	$14.05M	1.1%	$3.24	-4.3%	COM NEW	68235C206
SER	SERINA THERAPEUTICS INC	85,219	$570K	0.0%	$14.17	-44.0%	COM SHS	81751A108